Level of functioning · patients with anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability · people with social phobia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety · people with social phobia
1 finding from 1 review
Depression at endpoint · people with social phobia
1 finding from 1 review
Measures of obsession and compulsion endpoint data or change data · people with social phobia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life measures ‐ endpoint data or change data · people with social phobia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Level of functioning · people with social phobia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global state responders · patients with anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: acceptability of treatment · patients with anxiety disorders
It is very uncertain whether morita therapy plus pharmacological therapy changes acceptability drop‐outs for any reason compared with pharmacological therapy alone (very low certainty).
1 finding from 1 review
Depression score SCL‐90‐R depression sub‐scale (13 items); HAM‐D. Scale from: 0 to 84 (HAM‐D) or 52 (SCL‐90‐R depression sub‐scale). · patients with depression
1 finding from 1 review
Total number of drop‐outs · patients with depression
Dance Movement Therapy (DMT) showed no clear difference in drop‐outs drop‐out numbers in each arm compared with standard care or waiting list control (low certainty).
1 finding from 1 review
Social and occupational functioning · patients with depression
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · patients with depression
1 finding from 1 review
Self-esteem (Piers-Harris self-concept scale) · patients with depression
1 finding from 1 review
Repetition of SH at last · adults who engage in SH
Newer generation antidepressants showed no clear difference in repetition of SH at last compared with placebo (low certainty).
1 finding from 1 review
Repetition of SH at 6 months' · adults who engage in SH
It is very uncertain whether antipsychotics changes repetition of SH at six months (flupenthixol vs. placebo) compared with placebo or another comparator drug/dose (very low certainty).
1 finding from 1 review
Repetition of SH at six months (low dose fluphenazine vs. ultra low dose fluphenazine) · adults who engage in SH
It is very uncertain whether antipsychotics changes repetition of SH at six months (low dose fluphenazine vs. ultra low… compared with placebo or another comparator drug/dose (very low certainty).
1 finding from 1 review
Repetition of SH at 12 months · adults who engage in SH
Mood stabilisers showed no clear difference in repetition of SH at 12 months compared with placebo (low certainty).
1 finding from 1 review
Repetition of SH during 12 week treatment phase · adults who engage in SH
Natural products showed no clear difference in repetition of SH during 12 week treatment phase compared with placebo (low certainty).
1 finding from 1 review
Repetition of SH at 6 months' · children and adolescents who engage in SH.
It is very uncertain whether comparison 1: individual CBT‐based psychotherapy changes repetition of SH at six months compared with treatment (very low certainty).
1 finding from 1 review